NKTR

Nektar Therapeutics News Headlines

$13.07
*  
0.09
0.69%
Get NKTR Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading NKTR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
2/27/2015 4:00:00 PM - Seeking Alpha


Nektar CEO Howard Robin Walks Along His Own Path
2/25/2015 11:54:00 AM - Seeking Alpha


Nektar Starts Phase3 SUMMIT-07 Study Of NKTR-181 In Patients With CLow Back Pain
2/25/2015 9:38:00 AM - RTT News


ADMP Proves A Point, PETX Regains Drug Rights, CBAY Dips, NKTR On Watch
2/25/2015 1:02:00 AM - RTT News


Nektar Therapeutics Surge 5% As Q4 Results Top Estimates. Loss Narrows
2/24/2015 9:04:00 PM - RTT News


Nektar Therapeutics Reports Narrower Than Estimated Q4 Loss
2/24/2015 5:01:00 PM - RTT News


Nektar Therapeutics Q4 14 Earnings Conference Call At 5:00 PM ET
2/24/2015 3:00:00 PM - RTT News


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
2/13/2015 4:00:00 PM - Seeking Alpha


What The Chances Are Of BEACON's Success And What That Will Mean To Nektar
2/9/2015 12:56:00 PM - Seeking Alpha


Will Baxter International (BAX) Disappoint Earnings in Q4? - Analyst Blog
1/27/2015 3:45:00 AM - Investopedia


Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/15/2015 7:00:00 AM - Investopedia


Nektar Therapeutics To Present At J.P. Morgan Conference; Webcast At 2:00 PM ET
1/13/2015 1:01:00 PM - RTT News


Stocks Holding On To Modest Gains In Mid-Day Trading - U.S. Commentary
12/31/2014 11:57:00 AM - RTT News


Stocks Kick Off Final Trading Day Of 2014 On Upbeat Note - U.S. Commentary
12/31/2014 10:32:00 AM - RTT News


Baxter Seeks FDA Approval of BAX111 to Advance VWD Cure - Analyst Blog
12/23/2014 4:00:00 AM - Investopedia


INFI Makes A Mark, IRWD For The Long Haul, MOVENTIG Approved In EU
12/10/2014 12:15:00 AM - RTT News


Nektar Therapeutics Reports Approval Of MOVENTIG In EU - Quick Facts
12/9/2014 8:19:00 AM - RTT News


Nektar Therapeutics: 2015 - The Year Of Great Things?
11/11/2014 10:30:00 AM - Seeking Alpha


Update: AstraZeneca Moves Closer To EU Approval For Moventig
9/30/2014 3:41:00 AM - Seeking Alpha


Weighing The Week Ahead: Finding Stocks For The 2014 Homestretch
9/7/2014 4:56:00 AM - Seeking Alpha


Nektar 181 Could Dominate A $13B Chronic Pain Market
8/26/2014 8:33:00 AM - Seeking Alpha


Nektar Therapeutics Has More To Give
8/21/2014 1:45:00 PM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha


Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik
8/7/2014 12:36:00 PM - Seeking Alpha